Exact Mass: 602.3387586
Exact Mass Matches: 602.3387586
Found 500 metabolites which its exact mass value is equals to given mass value 602.3387586,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
(-)-Guttiferone E
Garcinol is a monoterpenoid. CID 5281560 is a natural product found in Garcinia assugu, Garcinia pedunculata, and other organisms with data available. (-)-Guttiferone E is found in fruits. (-)-Guttiferone E is a constituent of Garcinia indica (kokam). Camboginol isolated from Garcinia cambogia. Constituent of Garcinia indica (kokam). Camboginol isolated from Garcinia cambogia. (-)-Guttiferone E is found in fruits. Garcinol, a polyisoprenylated benzophenone harvested from Garcinia indica, exerts anti-cholinesterase properties towards acetyl cholinesterase (AChE) and butyrylcholinesterase (BChE) with IC50s of 0.66 μM and 7.39 μM, respectively[1]. Garcinol also inhibits histone acetyltransferases (HATs, IC50= 7 μM) and p300/CPB-associated factor (PCAF, IC50 = 5 μM). Garcinol has anti-inflammatory and anti-cancer activity[2].
Xanthochymol
Xanthochymol is found in fruits. Xanthochymol is a constituent of the famine food Garcinia xanthochymus
dolichyl beta-D-glucosyl phosphate
A polyprenyl glycosyl phosphate having dolichyl as the polyprenyl component and beta-D-glucose as the glycosyl component.
Physapruin B
Physapruin B is found in fruits. Physapruin B is a constituent of Physalis pruinosa (strawberry tomato).
(+)-Isoxanthochymol
(-)-Isoxanthochymol is found in herbs and spices. (-)-Isoxanthochymol is found in the latex of Garcinia indica (kokam) and Garcinia cambogi
Ganoderic acid Mg
Ganoderic acid Mg is found in mushrooms. Ganoderic acid Mg is a metabolite Ganoderma lucidum (reishi Metabolite Ganoderma lucidum (reishi). Ganoderic acid Mg is found in mushrooms.
Guttiferone A
Guttiferone A is found in fruits. Guttiferone A is a constituent of Garcinia livingstonei (imbe). Constituent of Garcinia livingstonei (imbe). Guttiferone A is found in fruits.
Tetronasin
Tetronasin is isolated from Streptomyces longisporoflavus. Investigated as ruminant feed additive. Isolated from Streptomyces longisporoflavus. Investigated as ruminant feed additive.
Elsibucol
PA(10:0/18:2(10E,12Z)+=O(9))
PA(10:0/18:2(10E,12Z)+=O(9)) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(10:0/18:2(10E,12Z)+=O(9)), in particular, consists of one chain of one decanoyl at the C-1 position and one chain of 9-oxo-octadecadienoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).
PA(18:2(10E,12Z)+=O(9)/10:0)
PA(18:2(10E,12Z)+=O(9)/10:0) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(18:2(10E,12Z)+=O(9)/10:0), in particular, consists of one chain of one 9-oxo-octadecadienoyl at the C-1 position and one chain of decanoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).
PA(10:0/18:2(9Z,11E)+=O(13))
PA(10:0/18:2(9Z,11E)+=O(13)) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(10:0/18:2(9Z,11E)+=O(13)), in particular, consists of one chain of one decanoyl at the C-1 position and one chain of 13-oxo-octadecadienoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).
PA(18:2(9Z,11E)+=O(13)/10:0)
PA(18:2(9Z,11E)+=O(13)/10:0) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(18:2(9Z,11E)+=O(13)/10:0), in particular, consists of one chain of one 13-oxo-octadecadienoyl at the C-1 position and one chain of decanoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).
PA(10:0/18:3(10,12,15)-OH(9))
PA(10:0/18:3(10,12,15)-OH(9)) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(10:0/18:3(10,12,15)-OH(9)), in particular, consists of one chain of one decanoyl at the C-1 position and one chain of 9-hydroxyoctadecatrienoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).
PA(18:3(10,12,15)-OH(9)/10:0)
PA(18:3(10,12,15)-OH(9)/10:0) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(18:3(10,12,15)-OH(9)/10:0), in particular, consists of one chain of one 9-hydroxyoctadecatrienoyl at the C-1 position and one chain of decanoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).
PA(10:0/18:3(9,11,15)-OH(13))
PA(10:0/18:3(9,11,15)-OH(13)) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(10:0/18:3(9,11,15)-OH(13)), in particular, consists of one chain of one decanoyl at the C-1 position and one chain of 13-hydroxyoctadecatrienoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).
PA(18:3(9,11,15)-OH(13)/10:0)
PA(18:3(9,11,15)-OH(13)/10:0) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(18:3(9,11,15)-OH(13)/10:0), in particular, consists of one chain of one 13-hydroxyoctadecatrienoyl at the C-1 position and one chain of decanoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).
PA(8:0/20:3(6,8,11)-OH(5))
PA(8:0/20:3(6,8,11)-OH(5)) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(8:0/20:3(6,8,11)-OH(5)), in particular, consists of one chain of one octanoyl at the C-1 position and one chain of 5-hydroxyeicosatetrienoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).
PA(20:3(6,8,11)-OH(5)/8:0)
PA(20:3(6,8,11)-OH(5)/8:0) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(20:3(6,8,11)-OH(5)/8:0), in particular, consists of one chain of one 5-hydroxyeicosatetrienoyl at the C-1 position and one chain of octanoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).
isoxanthochymol
A natural product found in Rheedia edulis and Garcinia livingstonei.
(-)-Guttiferone E
(-)-Guttiferone E is found in fruits. (-)-Guttiferone E is a constituent of Garcinia indica (kokam). Camboginol isolated from Garcinia cambogia. Constituent of Garcinia indica (kokam). Camboginol isolated from Garcinia cambogia. (-)-Guttiferone E is found in fruits. Garcinol, a polyisoprenylated benzophenone harvested from Garcinia indica, exerts anti-cholinesterase properties towards acetyl cholinesterase (AChE) and butyrylcholinesterase (BChE) with IC50s of 0.66 μM and 7.39 μM, respectively[1]. Garcinol also inhibits histone acetyltransferases (HATs, IC50= 7 μM) and p300/CPB-associated factor (PCAF, IC50 = 5 μM). Garcinol has anti-inflammatory and anti-cancer activity[2].
3??-[(??-L-Arabinopyranosyl)oxy]-19??-hydroxyurs-12,20(30)-dien-28-oic acid
8-benzoyl-6,10-di-(3-methyl-2-butenyl)-3-[5-(1-hydroxy-1methylethyl)-2-methyltetrahydrofuran-2-yl]-4-oxatricyclo[6,3,1,0(1,5)]dodecane-7,12-dione|otogirinin E
Trapoxin A
C34H42N4O6 (602.3104192000001)
A homodetic cyclic tetrapeptide constructed from L-phenylalanyl (x2), D-pipecolinyl and L-2-amino-8-oxo-9,10-epoxydecanoyl residues. D004791 - Enzyme Inhibitors > D056572 - Histone Deacetylase Inhibitors C471 - Enzyme Inhibitor > C1946 - Histone Deacetylase Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent D000970 - Antineoplastic Agents
12-(2,4-Undecadienoyl),13-Ac-(4beta,7beta,9alphabeta,12beta,13alpha)-7-Hydroperoxy-4,9,12,13,20-pentahydroxy-1,5-tigliadien-3-one
(11aR*)-8-[(2E)-3,7-dimethylocta-2,6-dien-1-yl]-3a,4,12,13-tetrahydro-3a,7,9-trihydroxy-3-(hydroxymethyl)-13,13-dimethyl-10-(3-methylbut-2-en-1-yl)-4,12-methanocyclopenta[c]furo[2,3-d]xanthen-6(1H)-one|gamboketanol
12-O-decanoylphorbol 13-O-(2-methylbutyrate)|12-O-decanoylphorbol-13-(2-methylbutyrate)
8,8-dimethyl-1-(3,4-dihydroxybenzoyl)-2-hydroxy-3,5-di(gamma,gamma-dimethylallyl)-7-(2-isopropenylhex-5-enyl)-7alphaH-trans-bicyclo[3.3.1]nona-2-en-4,9-dione|garcinielliptone FC
rel-18(S),19(R)-diacetoxy-18,19-epoxy-6(R)-hydroxy-2(S)-undecanoyloxy-5(R),8(S),9(S),10(R)-cleroda-3,13(16),14-triene
21alpha-hydroxyolean-12-ene-28-oic acid 3beta-4-oxo-pentopyranoside
11,12-di-O-ikemoyl stephnol|marsgenin|pregn-5-ene-11beta,12beta-di-O-ikemoyl,3beta,8beta,14beta,17beta,20-pentol
6-O-[(9Z,12Z,15Z)-octadeca-9,12,15-trienoyl]-beta-D-fructofuranosyl-(2->1)-alpha-D-glucopyranoside
11alpha,12alpha-epoxy-3-O-beta-D-xylopyranosylolean-28,13beta-olide
11alpha,15alpha-diacetoxybrachycarpon-22(23)-ene|15alpha-acetoxycleomblynol A
guttiferone F
A member of the class of benzophenones isolated from the stem bark of Allanblackia stuhlmannii and has been shown to exhibit antileishmanial and anticholinesterase activity.
(1RS,5RS,7RS,8SR)-3-(3,4-dihydroxybenzoyl)-4-hydroxy-8-methyl-1,5,7-tris(3-methylbut-2-en-1-yl)-8-(4-methylpent-3-en-1-yl)bicyclo[3.3.1]non-3-ene-2,9-dione|guttiferone A
Lys His Tyr Arg
C27H42N10O6 (602.3288632000001)
His Tyr Arg Lys
C27H42N10O6 (602.3288632000001)
cambogin
Garcinol is a monoterpenoid. CID 5281560 is a natural product found in Garcinia assugu, Garcinia pedunculata, and other organisms with data available. Isogarcinol is a natural product found in Garcinia pedunculata, Garcinia cowa, and other organisms with data available. Garcinol, a polyisoprenylated benzophenone harvested from Garcinia indica, exerts anti-cholinesterase properties towards acetyl cholinesterase (AChE) and butyrylcholinesterase (BChE) with IC50s of 0.66 μM and 7.39 μM, respectively[1]. Garcinol also inhibits histone acetyltransferases (HATs, IC50= 7 μM) and p300/CPB-associated factor (PCAF, IC50 = 5 μM). Garcinol has anti-inflammatory and anti-cancer activity[2].
7-epi-Isogarcinol
7-Epi-Isogarcinol is a natural product found in Symphonia globulifera, Garcinia griffithii, and other organisms with data available.
desferrioxamine D1
4,15,26-trihydroxy-1-oxa-4,9,15,20,26,31-hexazacyclotritriacontane-5,8,16,19,27,30-hexone
4,15,26-trihydroxy-1-oxa-4,9,15,20,26,31-hexazacyclotritriacontane-5,8,16,19,27,30-hexone_major
Glu Ile Arg Trp
C28H42N8O7 (602.3176301999999)
Glu Ile Trp Arg
C28H42N8O7 (602.3176301999999)
Glu Leu Arg Trp
C28H42N8O7 (602.3176301999999)
Glu Leu Trp Arg
C28H42N8O7 (602.3176301999999)
Glu Arg Ile Trp
C28H42N8O7 (602.3176301999999)
Glu Arg Leu Trp
C28H42N8O7 (602.3176301999999)
Glu Arg Trp Ile
C28H42N8O7 (602.3176301999999)
Glu Arg Trp Leu
C28H42N8O7 (602.3176301999999)
Glu Trp Ile Arg
C28H42N8O7 (602.3176301999999)
Glu Trp Leu Arg
C28H42N8O7 (602.3176301999999)
Glu Trp Arg Ile
C28H42N8O7 (602.3176301999999)
Glu Trp Arg Leu
C28H42N8O7 (602.3176301999999)
His Lys Arg Tyr
C27H42N10O6 (602.3288632000001)
His Lys Tyr Arg
C27H42N10O6 (602.3288632000001)
His Arg Lys Tyr
C27H42N10O6 (602.3288632000001)
His Arg Tyr Lys
C27H42N10O6 (602.3288632000001)
His Tyr Lys Arg
C27H42N10O6 (602.3288632000001)
Ile Glu Arg Trp
C28H42N8O7 (602.3176301999999)
Ile Glu Trp Arg
C28H42N8O7 (602.3176301999999)
Ile Arg Glu Trp
C28H42N8O7 (602.3176301999999)
Ile Arg Trp Glu
C28H42N8O7 (602.3176301999999)
Ile Val Trp Trp
Ile Trp Glu Arg
C28H42N8O7 (602.3176301999999)
Ile Trp Arg Glu
C28H42N8O7 (602.3176301999999)
Ile Trp Val Trp
Ile Trp Trp Val
Lys His Arg Tyr
C27H42N10O6 (602.3288632000001)
Lys Asn Arg Trp
C27H42N10O6 (602.3288632000001)
Lys Asn Trp Arg
C27H42N10O6 (602.3288632000001)
Lys Arg His Tyr
C27H42N10O6 (602.3288632000001)
Lys Arg Asn Trp
C27H42N10O6 (602.3288632000001)
Lys Arg Trp Asn
C27H42N10O6 (602.3288632000001)
Lys Arg Tyr His
C27H42N10O6 (602.3288632000001)
Lys Trp Asn Arg
C27H42N10O6 (602.3288632000001)
Lys Trp Arg Asn
C27H42N10O6 (602.3288632000001)
Lys Tyr His Arg
C27H42N10O6 (602.3288632000001)
Lys Tyr Arg His
C27H42N10O6 (602.3288632000001)
Leu Glu Arg Trp
C28H42N8O7 (602.3176301999999)
Leu Glu Trp Arg
C28H42N8O7 (602.3176301999999)
Leu Arg Glu Trp
C28H42N8O7 (602.3176301999999)
Leu Arg Trp Glu
C28H42N8O7 (602.3176301999999)
Leu Val Trp Trp
Leu Trp Glu Arg
C28H42N8O7 (602.3176301999999)
Leu Trp Arg Glu
C28H42N8O7 (602.3176301999999)
Leu Trp Val Trp
Leu Trp Trp Val
Asn Lys Arg Trp
C27H42N10O6 (602.3288632000001)
Asn Lys Trp Arg
C27H42N10O6 (602.3288632000001)
Asn Arg Lys Trp
C27H42N10O6 (602.3288632000001)
Asn Arg Trp Lys
C27H42N10O6 (602.3288632000001)
Asn Trp Lys Arg
C27H42N10O6 (602.3288632000001)
Asn Trp Arg Lys
C27H42N10O6 (602.3288632000001)
Arg Glu Ile Trp
C28H42N8O7 (602.3176301999999)
Arg Glu Leu Trp
C28H42N8O7 (602.3176301999999)
Arg Glu Trp Ile
C28H42N8O7 (602.3176301999999)
Arg Glu Trp Leu
C28H42N8O7 (602.3176301999999)
Arg His Lys Tyr
C27H42N10O6 (602.3288632000001)
Arg His Tyr Lys
C27H42N10O6 (602.3288632000001)
Arg Ile Glu Trp
C28H42N8O7 (602.3176301999999)
Arg Ile Trp Glu
C28H42N8O7 (602.3176301999999)
Arg Lys His Tyr
C27H42N10O6 (602.3288632000001)
Arg Lys Asn Trp
C27H42N10O6 (602.3288632000001)
Arg Lys Trp Asn
C27H42N10O6 (602.3288632000001)
Arg Lys Tyr His
C27H42N10O6 (602.3288632000001)
Arg Leu Glu Trp
C28H42N8O7 (602.3176301999999)
Arg Leu Trp Glu
C28H42N8O7 (602.3176301999999)
Arg Asn Lys Trp
C27H42N10O6 (602.3288632000001)
Arg Asn Trp Lys
C27H42N10O6 (602.3288632000001)
Arg Trp Glu Ile
C28H42N8O7 (602.3176301999999)
Arg Trp Glu Leu
C28H42N8O7 (602.3176301999999)
Arg Trp Ile Glu
C28H42N8O7 (602.3176301999999)
Arg Trp Lys Asn
C27H42N10O6 (602.3288632000001)
Arg Trp Leu Glu
C28H42N8O7 (602.3176301999999)
Arg Trp Asn Lys
C27H42N10O6 (602.3288632000001)
Arg Tyr His Lys
C27H42N10O6 (602.3288632000001)
Arg Tyr Lys His
C27H42N10O6 (602.3288632000001)
Val Ile Trp Trp
Val Leu Trp Trp
Val Trp Ile Trp
Val Trp Leu Trp
Val Trp Trp Ile
Val Trp Trp Leu
Trp Glu Ile Arg
C28H42N8O7 (602.3176301999999)
Trp Glu Leu Arg
C28H42N8O7 (602.3176301999999)
Trp Glu Arg Ile
C28H42N8O7 (602.3176301999999)
Trp Glu Arg Leu
C28H42N8O7 (602.3176301999999)
Trp Ile Glu Arg
C28H42N8O7 (602.3176301999999)
Trp Ile Arg Glu
C28H42N8O7 (602.3176301999999)
Trp Ile Val Trp
Trp Ile Trp Val
Trp Lys Asn Arg
C27H42N10O6 (602.3288632000001)
Trp Lys Arg Asn
C27H42N10O6 (602.3288632000001)
Trp Leu Glu Arg
C28H42N8O7 (602.3176301999999)
Trp Leu Arg Glu
C28H42N8O7 (602.3176301999999)
Trp Leu Val Trp
Trp Leu Trp Val
Trp Asn Lys Arg
C27H42N10O6 (602.3288632000001)
Trp Asn Arg Lys
C27H42N10O6 (602.3288632000001)
Trp Arg Glu Ile
C28H42N8O7 (602.3176301999999)
Trp Arg Glu Leu
C28H42N8O7 (602.3176301999999)
Trp Arg Ile Glu
C28H42N8O7 (602.3176301999999)
Trp Arg Lys Asn
C27H42N10O6 (602.3288632000001)
Trp Arg Leu Glu
C28H42N8O7 (602.3176301999999)
Trp Arg Asn Lys
C27H42N10O6 (602.3288632000001)
Trp Val Ile Trp
Trp Val Leu Trp
Trp Val Trp Ile
Trp Val Trp Leu
Trp Trp Ile Val
Trp Trp Leu Val
Trp Trp Val Ile
Trp Trp Val Leu
Tyr His Lys Arg
C27H42N10O6 (602.3288632000001)
Tyr His Arg Lys
C27H42N10O6 (602.3288632000001)
Tyr Lys His Arg
C27H42N10O6 (602.3288632000001)
Tyr Lys Arg His
C27H42N10O6 (602.3288632000001)
Tyr Arg His Lys
C27H42N10O6 (602.3288632000001)
Tyr Arg Lys His
C27H42N10O6 (602.3288632000001)
guttiferone A
Physapruin B
6-O-Linolenylsucrose
ELSIBUCOL
C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic C26170 - Protective Agent > C275 - Antioxidant
Withalongolide K
A steroid saponin that is the monosaccharide derivative of the 19-norwithanolide. It has been isolated from the aerial parts of Physalis longifolia.
(3E)-3-[(3,4-dihydroxyphenyl)-hydroxymethylidene]-6,6-dimethyl-5,7-bis(3-methylbut-2-enyl)-1-(5-methyl-2-prop-1-en-2-ylhex-5-enyl)bicyclo[3.3.1]nonane-2,4,9-trione
(3Z)-3-[(3,4-dihydroxyphenyl)-hydroxymethylidene]-6,6-dimethyl-5,7-bis(3-methylbut-2-enyl)-1-(5-methyl-2-prop-1-en-2-ylhex-4-enyl)bicyclo[3.3.1]nonane-2,4,9-trione
[(2R)-1-octanoyloxy-3-phosphonooxypropan-2-yl] (6E,8E,11E)-5-hydroxyicosa-6,8,11-trienoate
[(2R)-2-octanoyloxy-3-phosphonooxypropyl] (6E,8E,11E)-5-hydroxyicosa-6,8,11-trienoate
[(2R)-1-decanoyloxy-3-phosphonooxypropan-2-yl] (10E,12E,15E)-9-hydroxyoctadeca-10,12,15-trienoate
[(2R)-2-decanoyloxy-3-phosphonooxypropyl] (10E,12E,15E)-9-hydroxyoctadeca-10,12,15-trienoate
[(2R)-1-decanoyloxy-3-phosphonooxypropan-2-yl] (9E,11E,15E)-13-hydroxyoctadeca-9,11,15-trienoate
[(2R)-2-decanoyloxy-3-phosphonooxypropyl] (9E,11E,15E)-13-hydroxyoctadeca-9,11,15-trienoate
2-[[(2R)-3-acetyloxy-2-[(5Z,8Z,11Z)-13-(3-pentyloxiran-2-yl)trideca-5,8,11-trienoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
2-[[(2R)-2-acetyloxy-3-[(5Z,8Z,11Z)-13-(3-pentyloxiran-2-yl)trideca-5,8,11-trienoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
2-[[(2R)-3-acetyloxy-2-[(5Z,8Z)-10-[3-[(Z)-oct-2-enyl]oxiran-2-yl]deca-5,8-dienoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
2-[[(2R)-2-acetyloxy-3-[(5Z,8Z)-10-[3-[(Z)-oct-2-enyl]oxiran-2-yl]deca-5,8-dienoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
2-[[(2R)-3-acetyloxy-2-[(Z)-7-[3-[(2Z,5Z)-undeca-2,5-dienyl]oxiran-2-yl]hept-5-enoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
2-[[(2R)-2-acetyloxy-3-[(Z)-7-[3-[(2Z,5Z)-undeca-2,5-dienyl]oxiran-2-yl]hept-5-enoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
2-[[(2R)-3-acetyloxy-2-[4-[3-[(2Z,5Z,8Z)-tetradeca-2,5,8-trienyl]oxiran-2-yl]butanoyloxy]propoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
2-[[(2R)-2-acetyloxy-3-[4-[3-[(2Z,5Z,8Z)-tetradeca-2,5,8-trienyl]oxiran-2-yl]butanoyloxy]propoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
2-[[(2R)-3-acetyloxy-2-[(5Z,8Z,11Z,14Z)-20-hydroxyicosa-5,8,11,14-tetraenoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
2-[[(2R)-2-acetyloxy-3-[(5Z,8Z,11Z,14Z)-20-hydroxyicosa-5,8,11,14-tetraenoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
2-[[(2R)-3-acetyloxy-2-[(5R,6E,8Z,11Z,14Z)-5-hydroxyicosa-6,8,11,14-tetraenoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
2-[[(2R)-2-acetyloxy-3-[(5S,6E,8Z,11Z,14Z)-5-hydroxyicosa-6,8,11,14-tetraenoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
2-[[(2R)-3-acetyloxy-2-[(5Z,8Z,11Z,14Z,19S)-19-hydroxyicosa-5,8,11,14-tetraenoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
2-[[(2R)-2-acetyloxy-3-[(5Z,8Z,11Z,14Z,19R)-19-hydroxyicosa-5,8,11,14-tetraenoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
2-[[(2R)-3-acetyloxy-2-[(5Z,8Z,11Z,14Z,18R)-18-hydroxyicosa-5,8,11,14-tetraenoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
2-[[(2R)-2-acetyloxy-3-[(5Z,8Z,11Z,14Z,18S)-18-hydroxyicosa-5,8,11,14-tetraenoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
2-[[(2R)-3-acetyloxy-2-[(5Z,8Z,11Z,14Z)-17-hydroxyicosa-5,8,11,14-tetraenoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
2-[[(2R)-2-acetyloxy-3-[(5Z,8Z,11Z,14Z)-17-hydroxyicosa-5,8,11,14-tetraenoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
2-[[(2R)-3-acetyloxy-2-[(5Z,8Z,11Z,14Z,16R)-16-hydroxyicosa-5,8,11,14-tetraenoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
2-[[(2R)-2-acetyloxy-3-[(5Z,8Z,11Z,14Z,16S)-16-hydroxyicosa-5,8,11,14-tetraenoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
2-[[(2R)-3-acetyloxy-2-[(5Z,8Z,11Z,13E,15S)-15-hydroxyicosa-5,8,11,13-tetraenoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
2-[[(2R)-2-acetyloxy-3-[(5Z,8Z,11Z,13E,15R)-15-hydroxyicosa-5,8,11,13-tetraenoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
2-[[(2R)-3-acetyloxy-2-[(5Z,8Z,10E,12S,14Z)-12-hydroxyicosa-5,8,10,14-tetraenoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
2-[[(2R)-2-acetyloxy-3-[(5Z,8Z,10E,12R,14Z)-12-hydroxyicosa-5,8,10,14-tetraenoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
2-[[(2R)-3-acetyloxy-2-[(5E,8Z,11R,12Z,14Z)-11-hydroxyicosa-5,8,12,14-tetraenoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
2-[[(2R)-2-acetyloxy-3-[(5E,8Z,11S,12Z,14Z)-11-hydroxyicosa-5,8,12,14-tetraenoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
2-[[(2R)-3-acetyloxy-2-[(5E,7Z,11Z,14Z)-9-hydroxyicosa-5,7,11,14-tetraenoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
2-[[(2R)-2-acetyloxy-3-[(5E,7Z,11Z,14Z)-9-hydroxyicosa-5,7,11,14-tetraenoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
Garcinol
Garcinol, a polyisoprenylated benzophenone harvested from Garcinia indica, exerts anti-cholinesterase properties towards acetyl cholinesterase (AChE) and butyrylcholinesterase (BChE) with IC50s of 0.66 μM and 7.39 μM, respectively[1]. Garcinol also inhibits histone acetyltransferases (HATs, IC50= 7 μM) and p300/CPB-associated factor (PCAF, IC50 = 5 μM). Garcinol has anti-inflammatory and anti-cancer activity[2].
N-[(3R,9R,10S)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-[[methyl(pyridin-4-ylmethyl)amino]methyl]-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]benzamide
C35H46N4O5 (602.3468025999999)
[(6Z,10E,14E)-3,7,11,15,19-pentamethylicosa-6,10,14,18-tetraenyl] [(3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] hydrogen phosphate
4-(dimethylamino)-N-[(2R,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[(4-phenoxyphenyl)methyl]amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]butanamide
C35H46N4O5 (602.3468025999999)
4-(dimethylamino)-N-[(2S,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[(4-phenoxyphenyl)methyl]amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]butanamide
C35H46N4O5 (602.3468025999999)
4-(dimethylamino)-N-[(2R,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[(4-phenoxyphenyl)methyl]amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]butanamide
C35H46N4O5 (602.3468025999999)
4-(dimethylamino)-N-[(2S,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[(4-phenoxyphenyl)methyl]amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]butanamide
C35H46N4O5 (602.3468025999999)
4-(dimethylamino)-N-[(2S,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[(4-phenoxyphenyl)methyl]amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]butanamide
C35H46N4O5 (602.3468025999999)
N-[(3R,9S,10S)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-[[methyl(pyridin-4-ylmethyl)amino]methyl]-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]benzamide
C35H46N4O5 (602.3468025999999)
N-[(3S,9S,10R)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-[[methyl-(phenylmethyl)amino]methyl]-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-4-pyridinecarboxamide
C35H46N4O5 (602.3468025999999)
N-[(3R,9S,10S)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-[[methyl-(phenylmethyl)amino]methyl]-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-4-pyridinecarboxamide
C35H46N4O5 (602.3468025999999)
N-[(3S,9S,10R)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-[[methyl(pyridin-4-ylmethyl)amino]methyl]-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]benzamide
C35H46N4O5 (602.3468025999999)
N-[(3S,9S,10R)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-[[methyl-(phenylmethyl)amino]methyl]-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-4-pyridinecarboxamide
C35H46N4O5 (602.3468025999999)
N-[(3S,9S,10S)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-[[methyl(pyridin-4-ylmethyl)amino]methyl]-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]benzamide
C35H46N4O5 (602.3468025999999)
N-[(3S,9R,10S)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-[[methyl(pyridin-4-ylmethyl)amino]methyl]-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]benzamide
C35H46N4O5 (602.3468025999999)
N-[(3S,9R,10S)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-[[methyl-(phenylmethyl)amino]methyl]-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-4-pyridinecarboxamide
C35H46N4O5 (602.3468025999999)
N-[(3S,9S,10S)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-[[methyl-(phenylmethyl)amino]methyl]-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-4-pyridinecarboxamide
C35H46N4O5 (602.3468025999999)
4-(dimethylamino)-N-[(2R,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[(4-phenoxyphenyl)methyl]amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]butanamide
C35H46N4O5 (602.3468025999999)
4-(dimethylamino)-N-[(2R,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[(4-phenoxyphenyl)methyl]amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]butanamide
C35H46N4O5 (602.3468025999999)
N-[(3R,9R,10S)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-[[methyl-(phenylmethyl)amino]methyl]-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-4-pyridinecarboxamide
C35H46N4O5 (602.3468025999999)
4-(dimethylamino)-N-[(2S,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[(4-phenoxyphenyl)methyl]amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]butanamide
C35H46N4O5 (602.3468025999999)
N-[(3S,9R,10R)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-[[methyl-(phenylmethyl)amino]methyl]-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-4-pyridinecarboxamide
C35H46N4O5 (602.3468025999999)
N-[(3R,9S,10S)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-[[methyl-(phenylmethyl)amino]methyl]-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-4-pyridinecarboxamide
C35H46N4O5 (602.3468025999999)
N-[(3R,9S,10R)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-[[methyl-(phenylmethyl)amino]methyl]-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-4-pyridinecarboxamide
C35H46N4O5 (602.3468025999999)
N-[(3S,9R,10S)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-[[methyl-(phenylmethyl)amino]methyl]-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-4-pyridinecarboxamide
C35H46N4O5 (602.3468025999999)
N-[(3R,9R,10S)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-[[methyl-(phenylmethyl)amino]methyl]-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-4-pyridinecarboxamide
C35H46N4O5 (602.3468025999999)
N-[(3R,9R,10S)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-[[methyl(pyridin-4-ylmethyl)amino]methyl]-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]benzamide
C35H46N4O5 (602.3468025999999)
N-[(3S,9R,10R)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-[[methyl(pyridin-4-ylmethyl)amino]methyl]-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]benzamide
C35H46N4O5 (602.3468025999999)
N-[(3S,9R,10R)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-[[methyl(pyridin-4-ylmethyl)amino]methyl]-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]benzamide
C35H46N4O5 (602.3468025999999)
N-[(3S,9R,10R)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-[[methyl-(phenylmethyl)amino]methyl]-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-4-pyridinecarboxamide
C35H46N4O5 (602.3468025999999)
N-[(3R,9S,10R)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-[[methyl(pyridin-4-ylmethyl)amino]methyl]-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]benzamide
C35H46N4O5 (602.3468025999999)
N-[(3R,9R,10R)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-[[methyl(pyridin-4-ylmethyl)amino]methyl]-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]benzamide
C35H46N4O5 (602.3468025999999)
N-[(3R,9S,10S)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-[[methyl(pyridin-4-ylmethyl)amino]methyl]-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]benzamide
C35H46N4O5 (602.3468025999999)
N-[(3S,9S,10S)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-[[methyl(pyridin-4-ylmethyl)amino]methyl]-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]benzamide
C35H46N4O5 (602.3468025999999)
N-[(3R,9S,10R)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-[[methyl(pyridin-4-ylmethyl)amino]methyl]-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]benzamide
C35H46N4O5 (602.3468025999999)
N-[(3S,9S,10R)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-[[methyl(pyridin-4-ylmethyl)amino]methyl]-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]benzamide
C35H46N4O5 (602.3468025999999)
N-[(3R,9R,10R)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-[[methyl(pyridin-4-ylmethyl)amino]methyl]-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]benzamide
C35H46N4O5 (602.3468025999999)
N-[(3S,9R,10S)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-[[methyl(pyridin-4-ylmethyl)amino]methyl]-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]benzamide
C35H46N4O5 (602.3468025999999)
N-[(3R,9S,10R)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-[[methyl-(phenylmethyl)amino]methyl]-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-4-pyridinecarboxamide
C35H46N4O5 (602.3468025999999)
N-[(3S,9S,10S)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-[[methyl-(phenylmethyl)amino]methyl]-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-4-pyridinecarboxamide
C35H46N4O5 (602.3468025999999)
N-[(3R,9R,10R)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-[[methyl-(phenylmethyl)amino]methyl]-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-4-pyridinecarboxamide
C35H46N4O5 (602.3468025999999)
N-[(3R,9R,10R)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-[[methyl-(phenylmethyl)amino]methyl]-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-4-pyridinecarboxamide
C35H46N4O5 (602.3468025999999)
(1S,5R,7S)-3-[(3,4-dihydroxyphenyl)-oxomethyl]-6,6-dimethyl-5,7-bis(3-methylbut-2-enyl)-1-[(2S)-5-methyl-2-(1-methylethenyl)hex-4-enyl]bicyclo[3.3.1]nonane-2,4,9-trione
[1-[(2-hexanoyloxy-3-hydroxypropoxy)-hydroxyphosphoryl]oxy-3-hydroxypropan-2-yl] (6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoate
[1-hydroxy-3-[hydroxy-(3-hydroxy-2-octanoyloxypropoxy)phosphoryl]oxypropan-2-yl] (4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoate
[1-[(2-butanoyloxy-3-hydroxypropoxy)-hydroxyphosphoryl]oxy-3-hydroxypropan-2-yl] (8Z,11Z,14Z,17Z)-icosa-8,11,14,17-tetraenoate
[1-[(2-acetyloxy-3-hydroxypropoxy)-hydroxyphosphoryl]oxy-3-hydroxypropan-2-yl] (10Z,13Z,16Z,19Z)-docosa-10,13,16,19-tetraenoate
[1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-octanoyloxypropan-2-yl] (4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoate
[1-acetyloxy-3-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxypropan-2-yl] (10Z,13Z,16Z,19Z)-docosa-10,13,16,19-tetraenoate
[1-butanoyloxy-3-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxypropan-2-yl] (8Z,11Z,14Z,17Z)-icosa-8,11,14,17-tetraenoate
[1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-hexanoyloxypropan-2-yl] (6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoate
Guttiferone A (rel-(+))
A natural product found in Symphonia globulifera and Garcinia livingstonei.
guttiferone A, (rel-(+))-
A natural product found in Garcinia livingstonei and Rheedia edulis.
(1s,5s,6s,7s)-3-(3,4-dihydroxybenzoyl)-4-hydroxy-6-methyl-1,5,7-tris(3-methylbut-2-en-1-yl)-6-(4-methylpent-3-en-1-yl)bicyclo[3.3.1]non-3-ene-2,9-dione
(1r,2s,5r,9s,10r,12r)-5-[(r)-furan-3-yl(methoxy)methyl]-12-[(1r)-1-hydroxy-2-methoxy-2-oxoethyl]-6-(2-methoxy-2-oxoethyl)-1,5,11,11-tetramethyl-13-oxotricyclo[7.3.1.0²,⁷]tridec-6-en-10-yl 2-methylpropanoate
(1r,5r,7s)-3-(3,4-dihydroxybenzoyl)-5-[(2e)-3,7-dimethylocta-2,6-dien-1-yl]-4-hydroxy-8,8-dimethyl-1,7-bis(3-methylbut-2-en-1-yl)bicyclo[3.3.1]non-3-ene-2,9-dione
(3s,5r)-3-[(1r,2r,3r,5r,6r,9s,14r,15r,17r,18s,19s)-3,17-dihydroxy-2,6,14-trimethyl-9-phenyl-8-oxahexacyclo[16.3.1.0¹,¹⁸.0²,¹⁵.0⁵,¹⁴.0⁶,¹¹]docos-11-en-19-yl]-5-[(1e)-3-hydroxy-2-methylprop-1-en-1-yl]oxolan-2-one
[(1r,2s,3s,4s,5r,6s,8r,9s,10s,13s,16s,17r,18s)-11-ethyl-2,8,9-trihydroxy-4,6,16,18-tetramethoxy-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecan-13-yl]methyl 2-aminobenzoate
(1s,5r,7r)-3-[(3,4-dihydroxyphenyl)(hydroxy)methylidene]-6,6-dimethyl-5-[(2s)-5-methyl-2-(prop-1-en-2-yl)hex-4-en-1-yl]-1,7-bis(3-methylbut-3-en-1-yl)bicyclo[3.3.1]nonane-2,4,9-trione
9-(but-1-en-1-yl)-13-hydroxy-2-[(3-hydroxy-4,5-dimethoxy-6-methyloxan-2-yl)oxy]-14-methyl-1h,2h,3h,3ah,5ah,5bh,6h,9h,10h,11h,12h,13h,14h,16ah,16bh-as-indaceno[3,2-d]oxacyclododecane-7,15-dione
(1s,3s,9r,11r)-7-(3,4-dihydroxybenzoyl)-4,4,10,10-tetramethyl-9,11-bis(3-methylbut-2-en-1-yl)-3-(3-methylbut-3-en-1-yl)-5-oxatricyclo[7.3.1.0¹,⁶]tridec-6-ene-8,13-dione
3-(3,4-dihydroxybenzoyl)-4-hydroxy-8,8-dimethyl-5,7-bis(3-methylbut-2-en-1-yl)-1-[(2,4,4-trimethylcyclohex-1-en-1-yl)methyl]bicyclo[3.3.1]non-3-ene-2,9-dione
(1r,9r,16r,18r,21s)-6-[(15r,17s,19r)-15-ethyl-1,11-diazapentacyclo[9.6.2.0²,⁷.0⁸,¹⁸.0¹⁵,¹⁹]nonadeca-2,4,6,8(18)-tetraen-17-yl]-2,12-diazahexacyclo[14.2.2.1⁹,¹².0¹,⁹.0³,⁸.0¹⁶,²¹]henicosa-3,5,7-triene-18-carboxylic acid
8-(3,4-dihydroxybenzoyl)-2,2-dimethyl-4a-[5-methyl-2-(prop-1-en-2-yl)hex-4-en-1-yl]-3,6-bis(3-methylbut-2-en-1-yl)-4,6-dihydro-3h-1-benzopyran-5,7-dione
(1s,3z,5r,6s,7r)-3-[(3,4-dihydroxyphenyl)(hydroxy)methylidene]-6-methyl-1,5,7-tris(3-methylbut-2-en-1-yl)-6-(4-methylpent-3-en-1-yl)bicyclo[3.3.1]nonane-2,4,9-trione
(1r,3s,8s,13s,15s)-11-(3,4-dihydroxybenzoyl)-6,6,8,14,14-pentamethyl-13,15-bis(3-methylbut-2-en-1-yl)-9-oxatetracyclo[11.3.1.0¹,¹⁰.0³,⁸]heptadec-10-ene-12,17-dione
(1s,3s,8r,10r)-8-benzoyl-3-[(2r,5s)-5-(2-hydroxypropan-2-yl)-2-methyloxolan-2-yl]-9,9-dimethyl-6,10-bis(3-methylbut-2-en-1-yl)-4-oxatricyclo[6.3.1.0¹,⁵]dodec-5-ene-7,12-dione
6-benzyl-13-(hexan-2-yl)-5,8,11-trihydroxy-9-(1h-indol-3-ylmethyl)-3-(sec-butyl)-1-oxa-4,7,10-triazacyclotrideca-4,7,10-trien-2-one
C35H46N4O5 (602.3468025999999)
3-(3,4-dihydroxybenzoyl)-4-hydroxy-8,8-dimethyl-1,7-bis(3-methylbut-2-en-1-yl)-5-[(2,4,4-trimethylcyclohex-2-en-1-yl)methyl]bicyclo[3.3.1]non-3-ene-2,9-dione
(1r,5r,7r)-3-(3,4-dihydroxybenzoyl)-5-[(3r)-2,7-dimethylocta-1,6-dien-3-yl]-4-hydroxy-8,8-dimethyl-1,7-bis(3-methylbut-2-en-1-yl)bicyclo[3.3.1]non-3-ene-2,9-dione
4,8,15,19,26,30-hexahydroxy-1-oxa-4,9,15,20,26,31-hexaazacyclotritriaconta-8,19,30-triene-5,16,27-trione
3-[(1r,1'r,2s,3ar,3'ar,5r,7'r,7as,7'ar)-1'-[(2r)-1-[(2s)-3,4-dimethyl-5-oxo-2h-furan-2-yl]propan-2-yl]-2,7'-dihydroxy-3'a,4,4,7a,7'a-pentamethyl-4'-oxo-decahydro-1'h-1,5'-spirobi[inden]-5-yloxy]-3-oxopropanoic acid
(1s,5r,7r)-3-[(3,4-dihydroxyphenyl)(hydroxy)methylidene]-6,6-dimethyl-5,7-bis(3-methylbut-3-en-1-yl)-1-[(2,4,4-trimethylcyclohex-2-en-1-yl)methyl]bicyclo[3.3.1]nonane-2,4,9-trione
3-(3,4-dihydroxybenzoyl)-7-(3,7-dimethylocta-2,6-dien-1-yl)-4-hydroxy-8,8-dimethyl-1,5-bis(3-methylbut-2-en-1-yl)bicyclo[3.3.1]non-3-ene-2,9-dione
3,18-bis(acetyloxy)-2,7,7,11,12-pentamethyl-15-(2-methyl-5-oxofuran-2-yl)-5-oxo-6-oxatetracyclo[9.7.0.0²,⁸.0¹²,¹⁶]octadecan-13-yl acetate
(1s,5s,7s)-3-(3,4-dihydroxybenzoyl)-7-[(2e)-3,7-dimethylocta-2,6-dien-1-yl]-4-hydroxy-8,8-dimethyl-1,5-bis(3-methylbut-2-en-1-yl)bicyclo[3.3.1]non-3-ene-2,9-dione
5-[furan-3-yl(methoxy)methyl]-12-(1-hydroxy-2-methoxy-2-oxoethyl)-6-(2-methoxy-2-oxoethyl)-1,5,11,11-tetramethyl-13-oxotricyclo[7.3.1.0²,⁷]tridec-6-en-10-yl 2-methylpropanoate
(1s,2s,13s,14r,18s)-7-[(2e)-3,7-dimethylocta-2,6-dien-1-yl]-6,8,14-trihydroxy-15-(hydroxymethyl)-20,20-dimethyl-5-(3-methylbut-2-en-1-yl)-3,19-dioxahexacyclo[11.7.1.0²,¹¹.0²,¹⁸.0⁴,⁹.0¹⁴,¹⁸]henicosa-4,6,8,11,15-pentaen-10-one
5,6,11,14-tetrahydroxy-4-(hydroxymethyl)-8,12-dimethyl-7-oxo-14-(prop-1-en-2-yl)-3-oxatetracyclo[9.4.0.0²,⁴.0⁶,¹⁰]pentadec-8-en-15-yl tetradeca-2,4-dienoate
(2r,3s,8r,14s,19s)-19-butyl-8-(4-chlorobutyl)-3,14-dimethyltricyclo[18.2.2.2⁹,¹²]hexacosa-1(22),9,11,20,23,25-hexaene-2,10,21,24,26-pentol
C36H55ClO5 (602.3737809999999)
3-(3,4-dihydroxybenzoyl)-5-(3,7-dimethylocta-2,6-dien-1-yl)-4-hydroxy-8,8-dimethyl-1,7-bis(3-methylbut-2-en-1-yl)bicyclo[3.3.1]non-3-ene-2,9-dione
methyl (1s,14r,15e,18s)-12-[(1r,15r,17s,18s)-17-ethyl-3,13-diazapentacyclo[13.3.1.0²,¹⁰.0⁴,⁹.0¹³,¹⁸]nonadeca-2(10),4,6,8-tetraen-6-yl]-15-ethylidene-10,17-diazatetracyclo[12.3.1.0³,¹¹.0⁴,⁹]octadeca-3(11),4,6,8-tetraene-18-carboxylate
1-(3,4-dihydroxybenzoyl)-4-hydroxy-8,8-dimethyl-7-[5-methyl-2-(prop-1-en-2-yl)hex-5-en-1-yl]-3,5-bis(3-methylbut-2-en-1-yl)bicyclo[3.3.1]non-3-ene-2,9-dione
19-butyl-8-(4-chlorobutyl)-3,14-dimethyltricyclo[18.2.2.2⁹,¹²]hexacosa-1(22),9,11,20,23,25-hexaene-2,10,21,24,26-pentol
C36H55ClO5 (602.3737809999999)
(1s,5s,7r,8s)-3-(3,4-dihydroxybenzoyl)-4-hydroxy-8-methyl-1,5,7-tris(3-methylbut-2-en-1-yl)-8-(4-methylpent-3-en-1-yl)bicyclo[3.3.1]non-3-ene-2,9-dione
3-(3,4-dihydroxybenzoyl)-4-hydroxy-8,8-dimethyl-1-[5-methyl-2-(prop-1-en-2-yl)hex-5-en-1-yl]-5,7-bis(3-methylbut-2-en-1-yl)bicyclo[3.3.1]non-3-ene-2,9-dione
(1s,5s,7r)-3-(3,4-dihydroxybenzoyl)-7-[(2e)-3,7-dimethylocta-2,6-dien-1-yl]-4-hydroxy-8,8-dimethyl-1,5-bis(3-methylbut-2-en-1-yl)bicyclo[3.3.1]non-3-ene-2,9-dione
(1r,5s,7s)-3-[(3,4-dihydroxyphenyl)(hydroxy)methylidene]-6,6-dimethyl-1,7-bis(3-methylbut-3-en-1-yl)-5-[(2,4,4-trimethylcyclohex-1-en-1-yl)methyl]bicyclo[3.3.1]nonane-2,4,9-trione
(1s,3s,9s,11r)-7-(3,4-dihydroxybenzoyl)-4,4,10,10-tetramethyl-3,9,11-tris(3-methylbut-2-en-1-yl)-5-oxatricyclo[7.3.1.0¹,⁶]tridec-6-ene-8,13-dione
(1s,2r,3r,8r,11r,12r,13s,15s,16r,18r)-3,18-bis(acetyloxy)-2,7,7,11,12-pentamethyl-15-[(2s)-2-methyl-5-oxofuran-2-yl]-5-oxo-6-oxatetracyclo[9.7.0.0²,⁸.0¹²,¹⁶]octadecan-13-yl acetate
(3s,5r)-3-[(1r,2r,3r,5r,6r,9s,14s,15r,17r,18s,19s)-3,17-dihydroxy-2,6,14-trimethyl-9-phenyl-8-oxahexacyclo[16.3.1.0¹,¹⁸.0²,¹⁵.0⁵,¹⁴.0⁶,¹¹]docos-11-en-19-yl]-5-[(1e)-3-hydroxy-2-methylprop-1-en-1-yl]oxolan-2-one
2-[(1r,9r,10s,11r,13s,17r,25s,26s,27s,28e,33s,36s,38e,39s)-38-(2-hydroxyethylidene)-35-oxa-8,14,24,30-tetraazadodecacyclo[25.5.2.2¹¹,¹⁴.1¹,⁸.1⁹,²⁵.1¹⁰,¹⁷.0²,⁷.0¹³,¹⁷.0¹⁸,²³.0³⁰,³³.0²⁴,³⁶.0²⁶,³⁹]nonatriaconta-2,4,6,18,20,22-hexaen-28-ylidene]ethanol
7-(3,7-dimethylocta-2,6-dien-1-yl)-6,8,14-trihydroxy-15-(hydroxymethyl)-20,20-dimethyl-5-(3-methylbut-2-en-1-yl)-3,19-dioxahexacyclo[11.7.1.0²,¹¹.0²,¹⁸.0⁴,⁹.0¹⁴,¹⁸]henicosa-4,6,8,11,15-pentaen-10-one
(1r,5s,7s)-5-(3,4-dihydroxybenzoyl)-4-hydroxy-6,6-dimethyl-1-[(2s)-5-methyl-2-(prop-1-en-2-yl)hex-4-en-1-yl]-3,7-bis(3-methylbut-2-en-1-yl)bicyclo[3.3.1]non-3-ene-2,9-dione
[(1s,2r,3s)-1,2-dihydroxy-3-methoxy-2-[(2s,3s)-2-methyl-3-(3-methylbut-2-en-1-yl)oxiran-2-yl]-4-oxocyclohexyl]methyl (2r)-2-hydroxy-3-[(1s,5s,7r)-7-methyl-2-methylidene-7-(4-methylpenta-1,3-dien-1-yl)-6-oxabicyclo[3.2.1]octan-5-yl]propanoate
3-[hydroxy({5-[(1-hydroxyethylidene)amino]pentyl})carbamoyl]-n-[5-(n-hydroxy-3-{[5-(n-hydroxyacetamido)pentyl]-c-hydroxycarbonimidoyl}propanamido)pentyl]propanimidic acid
9-(but-1-en-1-yl)-13-hydroxy-2-[(4-hydroxy-3,5-dimethoxy-6-methyloxan-2-yl)oxy]-14-methyl-1h,2h,3h,3ah,5ah,5bh,6h,9h,10h,11h,12h,13h,14h,16ah,16bh-as-indaceno[3,2-d]oxacyclododecane-7,15-dione
12-(3,4-dihydroxybenzoyl)-13-hydroxy-3,3,9,9-tetramethyl-8,10-bis(3-methylbut-2-en-1-yl)-4-(prop-1-en-2-yl)tricyclo[8.3.1.0¹,⁷]tetradec-12-ene-11,14-dione
(1r,3e,5s,7s)-3-[(3,4-dihydroxyphenyl)(hydroxy)methylidene]-6,6-dimethyl-1-[(2r)-5-methyl-2-(prop-1-en-2-yl)hex-4-en-1-yl]-5,7-bis(3-methylbut-2-en-1-yl)bicyclo[3.3.1]nonane-2,4,9-trione
(1r,5r,7r)-3-(3,4-dihydroxybenzoyl)-4-hydroxy-8,8-dimethyl-5-[(2s)-5-methyl-2-(prop-1-en-2-yl)hex-4-en-1-yl]-1,7-bis(3-methylbut-2-en-1-yl)bicyclo[3.3.1]non-3-ene-2,9-dione
(1s,3r,9s,11r)-7-(3,4-dihydroxybenzoyl)-4,4,10,10-tetramethyl-3,9,11-tris(3-methylbut-2-en-1-yl)-5-oxatricyclo[7.3.1.0¹,⁶]tridec-6-ene-8,13-dione
methyl 2-[(1z,2s,3as,3bs,4r,5r,6s,7r,9as)-2,5-bis(acetyloxy)-4,7-dihydroxy-3a,3b,6,9a-tetramethyl-10-oxo-dodecahydrocyclopenta[a]phenanthren-1-ylidene]-6-methylhept-5-enoate
2,5-dimethoxy-3-[7-(3-methylbut-2-en-1-yl)-1h-indol-3-yl]-6-[7-(3-methylbut-2-en-1-yl)-2-(2-methylbut-3-en-2-yl)-1h-indol-3-yl]cyclohexa-2,5-diene-1,4-dione
(1r,3r,9s,11r)-7-(3,4-dihydroxybenzoyl)-4,4,10,10-tetramethyl-9,11-bis(3-methylbut-2-en-1-yl)-3-(3-methylbut-3-en-1-yl)-5-oxatricyclo[7.3.1.0¹,⁶]tridec-6-ene-8,13-dione
(1s,5s,7s)-3-(3,4-dihydroxybenzoyl)-4-hydroxy-8,8-dimethyl-5,7-bis(3-methylbut-2-en-1-yl)-1-[(2,4,4-trimethylcyclohex-1-en-1-yl)methyl]bicyclo[3.3.1]non-3-ene-2,9-dione
6-{15-ethyl-1,11-diazapentacyclo[9.6.2.0²,⁷.0⁸,¹⁸.0¹⁵,¹⁹]nonadeca-2,4,6,8(18)-tetraen-17-yl}-2,12-diazahexacyclo[14.2.2.1⁹,¹².0¹,⁹.0³,⁸.0¹⁶,²¹]henicosa-3,5,7-triene-18-carboxylic acid
3-{1'-[1-(3,4-dimethyl-5-oxo-2h-furan-2-yl)propan-2-yl]-2,7'-dihydroxy-3'a,4,4,7a,7'a-pentamethyl-4'-oxo-decahydro-1'h-1,5'-spirobi[inden]-5-yloxy}-3-oxopropanoic acid
(1s,5r)-3-[(3,4-dihydroxyphenyl)(hydroxy)methylidene]-6,6-dimethyl-1-[5-methyl-2-(prop-1-en-2-yl)hex-4-en-1-yl]-5,7-bis(3-methylbut-2-en-1-yl)bicyclo[3.3.1]nonane-2,4,9-trione
(1s,3z,5r,7r)-3-[(3,4-dihydroxyphenyl)(hydroxy)methylidene]-6,6-dimethyl-1-[(2r)-5-methyl-2-(prop-1-en-2-yl)hex-4-en-1-yl]-5,7-bis(3-methylbut-2-en-1-yl)bicyclo[3.3.1]nonane-2,4,9-trione
(1s,3ar,6ar,12ar)-9-[(2e)-3,7-dimethylocta-2,6-dien-1-yl]-8,10-dihydroxy-3,3,5'-trimethyl-11-(3-methylbut-2-en-1-yl)-4,6a-dihydro-3'h,3ah-spiro[furo[3,4-e]xanthene-1,2'-pyran]-6',7-dione
[(1s,2r,3s)-1,2-dihydroxy-3-methoxy-2-[(2s,3s)-2-methyl-3-(3-methylbut-2-en-1-yl)oxiran-2-yl]-4-oxocyclohexyl]methyl (2r)-2-hydroxy-3-[(1s,5s,7s)-7-methyl-2-methylidene-7-(4-methylpenta-1,3-dien-1-yl)-6-oxabicyclo[3.2.1]octan-5-yl]propanoate
8-benzoyl-3-[5-(2-hydroxypropan-2-yl)-2-methyloxolan-2-yl]-9,9-dimethyl-6,10-bis(3-methylbut-2-en-1-yl)-4-oxatricyclo[6.3.1.0¹,⁵]dodec-5-ene-7,12-dione
(1r,5r,7r)-3-(3,4-dihydroxybenzoyl)-4-hydroxy-8,8-dimethyl-1,7-bis(3-methylbut-2-en-1-yl)-5-{[(1r)-2,4,4-trimethylcyclohex-2-en-1-yl]methyl}bicyclo[3.3.1]non-3-ene-2,9-dione
(1s,4s,7s,8s,10s)-12-(3,4-dihydroxybenzoyl)-13-hydroxy-3,3,9,9-tetramethyl-8,10-bis(3-methylbut-2-en-1-yl)-4-(prop-1-en-2-yl)tricyclo[8.3.1.0¹,⁷]tetradec-12-ene-11,14-dione
15-benzyl-5,14-dihydroxy-6-isopropyl-3,9,10,12,16-pentamethyl-18-(2-methylpropyl)-1,7-dioxa-4,10,13,16-tetraazacyclooctadeca-4,13-diene-2,8,11,17-tetrone
3-[(3,4-dihydroxyphenyl)(hydroxy)methylidene]-6,6-dimethyl-1-[5-methyl-2-(prop-1-en-2-yl)hex-5-en-1-yl]-5,7-bis(3-methylbut-2-en-1-yl)bicyclo[3.3.1]nonane-2,4,9-trione
(1r,3e,5s,7r)-3-[(3,4-dihydroxyphenyl)(hydroxy)methylidene]-7-[(2e)-3,7-dimethylocta-2,6-dien-1-yl]-6,6-dimethyl-1,5-bis(3-methylbut-2-en-1-yl)bicyclo[3.3.1]nonane-2,4,9-trione
(1r,5r,7r)-5-(3,4-dihydroxybenzoyl)-1-[(3r)-2,7-dimethylocta-1,6-dien-3-yl]-4-hydroxy-6,6-dimethyl-3,7-bis(3-methylbut-2-en-1-yl)bicyclo[3.3.1]non-3-ene-2,9-dione
(3r,6s,9s,13r)-6-benzyl-3-[(2r)-butan-2-yl]-13-[(2s)-hexan-2-yl]-5,8,11-trihydroxy-9-(1h-indol-3-ylmethyl)-1-oxa-4,7,10-triazacyclotrideca-4,7,10-trien-2-one
C35H46N4O5 (602.3468025999999)
(1r,5s,7r)-3-[(3,4-dihydroxyphenyl)(hydroxy)methylidene]-6,6-dimethyl-1-[(2r)-5-methyl-2-(prop-1-en-2-yl)hex-4-en-1-yl]-5,7-bis(3-methylbut-2-en-1-yl)bicyclo[3.3.1]nonane-2,4,9-trione
(1s,5s,7s)-3-(3,4-dihydroxybenzoyl)-5-[(2e)-3,7-dimethylocta-2,6-dien-1-yl]-4-hydroxy-8,8-dimethyl-1,7-bis(3-methylbut-2-en-1-yl)bicyclo[3.3.1]non-3-ene-2,9-dione
(3r,6s,9s,13s)-6-benzyl-13-[(2s)-hexan-2-yl]-5,8,11-trihydroxy-9-(1h-indol-3-ylmethyl)-3-(2-methylpropyl)-1-oxa-4,7,10-triazacyclotrideca-4,7,10-trien-2-one
C35H46N4O5 (602.3468025999999)
(2r,3as,5ar,5bs,9r,13s,14r,16as,16br)-9-[(1e)-but-1-en-1-yl]-13-hydroxy-2-{[(2r,3r,4r,5r,6s)-4-hydroxy-3,5-dimethoxy-6-methyloxan-2-yl]oxy}-14-methyl-1h,2h,3h,3ah,5ah,5bh,6h,9h,10h,11h,12h,13h,14h,16ah,16bh-as-indaceno[3,2-d]oxacyclododecane-7,15-dione
(1r,5r,7s)-1-(3,4-dihydroxybenzoyl)-4-hydroxy-8,8-dimethyl-7-[(2s)-5-methyl-2-(prop-1-en-2-yl)hex-5-en-1-yl]-3,5-bis(3-methylbut-2-en-1-yl)bicyclo[3.3.1]non-3-ene-2,9-dione
(1r,3r,9s,11s)-7-(3,4-dihydroxybenzoyl)-4,4,10,10-tetramethyl-9,11-bis(3-methylbut-2-en-1-yl)-3-(3-methylbut-3-en-1-yl)-5-oxatricyclo[7.3.1.0¹,⁶]tridec-6-ene-8,13-dione
2-({[(3as,7as)-6-hydroxy-1-[(2s)-2-[(1-hydroxyhexylidene)amino]-3-(4-hydroxyphenyl)propanoyl]-octahydroindol-2-yl](hydroxy)methylidene}amino)-5-carbamimidamidopentanoic acid
(1r,5r,7s)-3-(3,4-dihydroxybenzoyl)-4-hydroxy-8,8-dimethyl-5,7-bis(3-methylbut-2-en-1-yl)-1-[(2,4,4-trimethylcyclohex-1-en-1-yl)methyl]bicyclo[3.3.1]non-3-ene-2,9-dione
(1s,3s,9r,11s)-7-(3,4-dihydroxybenzoyl)-4,4,10,10-tetramethyl-3,9,11-tris(3-methylbut-2-en-1-yl)-5-oxatricyclo[7.3.1.0¹,⁶]tridec-6-ene-8,13-dione
(1r,3e,5s,6r,7s)-3-[(3,4-dihydroxyphenyl)(hydroxy)methylidene]-6-methyl-1,5,7-tris(3-methylbut-2-en-1-yl)-6-(4-methylpent-3-en-1-yl)bicyclo[3.3.1]nonane-2,4,9-trione
(2r,3as,5ar,5bs,9r,13s,14r,16as,16br)-9-[(1e)-but-1-en-1-yl]-13-hydroxy-2-{[(2r,3r,4s,5s,6s)-3-hydroxy-4,5-dimethoxy-6-methyloxan-2-yl]oxy}-14-methyl-1h,2h,3h,3ah,5ah,5bh,6h,9h,10h,11h,12h,13h,14h,16ah,16bh-as-indaceno[3,2-d]oxacyclododecane-7,15-dione
(9r,11r)-7-(3,4-dihydroxybenzoyl)-4,4,10,10-tetramethyl-3,9,11-tris(3-methylbut-2-en-1-yl)-5-oxatricyclo[7.3.1.0¹,⁶]tridec-6-ene-8,13-dione
(1s,3e,5r,7r)-3-[(3,4-dihydroxyphenyl)(hydroxy)methylidene]-7-[(2e)-3,7-dimethylocta-2,6-dien-1-yl]-6,6-dimethyl-1,5-bis(3-methylbut-2-en-1-yl)bicyclo[3.3.1]nonane-2,4,9-trione
5-(3,4-dihydroxybenzoyl)-4-hydroxy-6,6-dimethyl-7-[5-methyl-2-(prop-1-en-2-yl)hex-5-en-1-yl]-1,3-bis(3-methylbut-2-en-1-yl)bicyclo[3.3.1]non-3-ene-2,9-dione
2-[({3-hydroxy-5-methoxy-6-methyl-4-[(2-methylhexa-2,4-dienoyl)oxy]oxan-2-yl}oxy)methyl]-9-(hydroxymethyl)-13-isopropyl-5-methyltetracyclo[7.4.0.0²,¹¹.0⁴,⁸]tridec-12-ene-1-carboxylic acid
(1s,3z,5r,7r)-3-[(3,4-dihydroxyphenyl)(hydroxy)methylidene]-6,6-dimethyl-1-[(2s)-5-methyl-2-(prop-1-en-2-yl)hex-4-en-1-yl]-5,7-bis(3-methylbut-2-en-1-yl)bicyclo[3.3.1]nonane-2,4,9-trione
(1s,3s,9r,11r)-7-(3,4-dihydroxybenzoyl)-4,4,10,10-tetramethyl-3,9,11-tris(3-methylbut-2-en-1-yl)-5-oxatricyclo[7.3.1.0¹,⁶]tridec-6-ene-8,13-dione
(1s,5s,7s)-3-(3,4-dihydroxybenzoyl)-4-hydroxy-8,8-dimethyl-5-[(2s)-5-methyl-2-(prop-1-en-2-yl)hex-4-en-1-yl]-1,7-bis(3-methylbut-2-en-1-yl)bicyclo[3.3.1]non-3-ene-2,9-dione
{1,2-dihydroxy-3-methoxy-2-[2-methyl-3-(3-methylbut-2-en-1-yl)oxiran-2-yl]-4-oxocyclohexyl}methyl 2-hydroxy-3-[7-methyl-2-methylidene-7-(4-methylpenta-1,3-dien-1-yl)-6-oxabicyclo[3.2.1]octan-5-yl]propanoate
9-[(2e)-3,7-dimethylocta-2,6-dien-1-yl]-8,10-dihydroxy-3,3,5'-trimethyl-11-(3-methylbut-2-en-1-yl)-4,6a-dihydro-3'h,3ah-spiro[furo[3,4-e]xanthene-1,2'-pyran]-6',7-dione
{11-ethyl-2,8,9-trihydroxy-4,6,16,18-tetramethoxy-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecan-13-yl}methyl 2-aminobenzoate
(1r,5r,7s)-3-(3,4-dihydroxybenzoyl)-4-hydroxy-8,8-dimethyl-5-[(2s)-5-methyl-2-(prop-1-en-2-yl)hex-4-en-1-yl]-1,7-bis(3-methylbut-2-en-1-yl)bicyclo[3.3.1]non-3-ene-2,9-dione
11-(3,4-dihydroxybenzoyl)-3,6,6,14,14-pentamethyl-13,15-bis(3-methylbut-2-en-1-yl)-9-oxatetracyclo[11.3.1.0¹,¹⁰.0³,⁸]heptadec-10-ene-12,17-dione
(1s,3ar,6as,12ar)-9-[(2e)-3,7-dimethylocta-2,6-dien-1-yl]-8,10-dihydroxy-3,3,5'-trimethyl-11-(3-methylbut-2-en-1-yl)-4,6a-dihydro-3'h,3ah-spiro[furo[3,4-e]xanthene-1,2'-pyran]-6',7-dione
(3s,6s,9s,15ar)-6,9-dibenzyl-1,4,7-trihydroxy-3-{6-[(2s)-oxiran-2-yl]-6-oxohexyl}-3h,6h,9h,12h,13h,14h,15h,15ah-pyrido[1,2-a]1,4,7,10-tetraazacyclododecan-10-one
C34H42N4O6 (602.3104192000001)
3-(3,4-dihydroxybenzoyl)-4-hydroxy-6-methyl-1,5,7-tris(3-methylbut-2-en-1-yl)-6-(4-methylpent-3-en-1-yl)bicyclo[3.3.1]non-3-ene-2,9-dione
(1s,2s,4r,5r,8r,9s,11s)-2-({[(2r,3s,4s,5r,6r)-3-hydroxy-5-methoxy-6-methyl-4-{[(2z,4e)-2-methylhexa-2,4-dienoyl]oxy}oxan-2-yl]oxy}methyl)-9-(hydroxymethyl)-13-isopropyl-5-methyltetracyclo[7.4.0.0²,¹¹.0⁴,⁸]tridec-12-ene-1-carboxylic acid
(1r,3e,5s,7s)-3-[(3,4-dihydroxyphenyl)(hydroxy)methylidene]-6,6-dimethyl-1-[(2r)-5-methyl-2-(prop-1-en-2-yl)hex-5-en-1-yl]-5,7-bis(3-methylbut-2-en-1-yl)bicyclo[3.3.1]nonane-2,4,9-trione
(1r,2s,4r,5s,6s,10s,11r,12r,14r,15r)-5,6,11,15-tetrahydroxy-4-(hydroxymethyl)-8,12-dimethyl-7-oxo-14-(prop-1-en-2-yl)-3-oxatetracyclo[9.4.0.0²,⁴.0⁶,¹⁰]pentadec-8-en-14-yl (2z,4e)-tetradeca-2,4-dienoate
(1s,5s,7r)-3-(3,4-dihydroxybenzoyl)-5-[(2e)-3,7-dimethylocta-2,6-dien-1-yl]-4-hydroxy-8,8-dimethyl-1,7-bis(3-methylbut-2-en-1-yl)bicyclo[3.3.1]non-3-ene-2,9-dione
9-(3,7-dimethylocta-2,6-dien-1-yl)-8,10-dihydroxy-3,3,5'-trimethyl-11-(3-methylbut-2-en-1-yl)-4,6a-dihydro-3'h,3ah-spiro[furo[3,4-e]xanthene-1,2'-pyran]-6',7-dione
(1s,5s,7s)-5-(3,4-dihydroxybenzoyl)-4-hydroxy-6,6-dimethyl-7-[(2s)-5-methyl-2-(prop-1-en-2-yl)hex-5-en-1-yl]-1,3-bis(3-methylbut-2-en-1-yl)bicyclo[3.3.1]non-3-ene-2,9-dione
(3s,4ar,6s)-8-(3,4-dihydroxybenzoyl)-2,2-dimethyl-4a-[(2s)-5-methyl-2-(prop-1-en-2-yl)hex-4-en-1-yl]-3,6-bis(3-methylbut-2-en-1-yl)-4,6-dihydro-3h-1-benzopyran-5,7-dione
(1s,9r,16s,18r,21s)-6-[(15s,17s,19r)-15-ethyl-1,11-diazapentacyclo[9.6.2.0²,⁷.0⁸,¹⁸.0¹⁵,¹⁹]nonadeca-2,4,6,8(18)-tetraen-17-yl]-2,12-diazahexacyclo[14.2.2.1⁹,¹².0¹,⁹.0³,⁸.0¹⁶,²¹]henicosa-3,5,7-triene-18-carboxylic acid
5-(3,4-dihydroxybenzoyl)-1-(2,7-dimethylocta-1,6-dien-3-yl)-4-hydroxy-6,6-dimethyl-3,7-bis(3-methylbut-2-en-1-yl)bicyclo[3.3.1]non-3-ene-2,9-dione
(1r,5s,7r)-3-[(3,4-dihydroxyphenyl)(hydroxy)methylidene]-6,6-dimethyl-1-[(2r)-5-methyl-2-(prop-1-en-2-yl)hex-5-en-1-yl]-5,7-bis(3-methylbut-2-en-1-yl)bicyclo[3.3.1]nonane-2,4,9-trione
2-[(38e)-38-(2-hydroxyethylidene)-35-oxa-8,14,24,30-tetraazadodecacyclo[25.5.2.2¹¹,¹⁴.1¹,⁸.1⁹,²⁵.1¹⁰,¹⁷.0²,⁷.0¹³,¹⁷.0¹⁸,²³.0³⁰,³³.0²⁴,³⁶.0²⁶,³⁹]nonatriaconta-2,4,6,18,20,22-hexaen-28-ylidene]ethanol
2,5-dimethoxy-3-[7-(3-methylbut-2-en-1-yl)-2-(2-methylbut-3-en-2-yl)-1h-indol-3-yl]-6-[2-(2-methylbut-3-en-2-yl)-1h-indol-3-yl]cyclohexa-2,5-diene-1,4-dione
(3s,6s,9s,12r,15r,18s)-15-benzyl-5,14-dihydroxy-6-isopropyl-3,9,10,12,16-pentamethyl-18-(2-methylpropyl)-1,7-dioxa-4,10,13,16-tetraazacyclooctadeca-4,13-diene-2,8,11,17-tetrone
(2r,3as,7as)-n-(5-carbamimidamido-1-oxopentan-2-yl)-1-[(2r)-2-{[(2r)-1,2-dihydroxy-3-(4-hydroxyphenyl)propylidene]amino}-4-methylpentanoyl]-6-hydroxy-octahydroindole-2-carboximidic acid
(1r,5s,6s,7r)-3-[(3,4-dihydroxyphenyl)(hydroxy)methylidene]-6-methyl-1,5,7-tris(3-methylbut-2-en-1-yl)-6-(4-methylpent-3-en-1-yl)bicyclo[3.3.1]nonane-2,4,9-trione
3-(3,4-dihydroxybenzoyl)-5-(2,7-dimethylocta-1,6-dien-3-yl)-4-hydroxy-8,8-dimethyl-1,7-bis(3-methylbut-2-en-1-yl)bicyclo[3.3.1]non-3-ene-2,9-dione
(1s,3r,9r,11r)-7-(3,4-dihydroxybenzoyl)-4,4,10,10-tetramethyl-3,9,11-tris(3-methylbut-2-en-1-yl)-5-oxatricyclo[7.3.1.0¹,⁶]tridec-6-ene-8,13-dione
(1r,5r,7r)-3-(3,4-dihydroxybenzoyl)-4-hydroxy-8,8-dimethyl-5-[(2r)-5-methyl-2-(prop-1-en-2-yl)hex-5-en-1-yl]-1,7-bis(3-methylbut-2-en-1-yl)bicyclo[3.3.1]non-3-ene-2,9-dione
(1r,3z,5s,7s)-3-[(3,4-dihydroxyphenyl)(hydroxy)methylidene]-6,6-dimethyl-1-[(2r)-5-methyl-2-(prop-1-en-2-yl)hex-5-en-1-yl]-5,7-bis(3-methylbut-2-en-1-yl)bicyclo[3.3.1]nonane-2,4,9-trione
(1s,2s,4r,5s,6s,10s,11r,12r,14r,15r)-5,6,11,14-tetrahydroxy-4-(hydroxymethyl)-8,12-dimethyl-7-oxo-14-(prop-1-en-2-yl)-3-oxatetracyclo[9.4.0.0²,⁴.0⁶,¹⁰]pentadec-8-en-15-yl (2e,4e)-tetradeca-2,4-dienoate
(1r,2s,4r,5s,6s,10s,11r,12r,14r,15r)-5,6,11,15-tetrahydroxy-4-(hydroxymethyl)-8,12-dimethyl-7-oxo-14-(prop-1-en-2-yl)-3-oxatetracyclo[9.4.0.0²,⁴.0⁶,¹⁰]pentadec-8-en-14-yl (4e)-tetradeca-2,4-dienoate
6,9-dibenzyl-1,4,7-trihydroxy-3-[6-(oxiran-2-yl)-6-oxohexyl]-3h,6h,9h,12h,13h,14h,15h,15ah-pyrido[1,2-a]1,4,7,10-tetraazacyclododecan-10-one
C34H42N4O6 (602.3104192000001)